Healthcare
Alnylam Pharmaceuticals, Inc. (ALNY)
61/ 100 Tessera Quality Score
Snapshot
- Market Cap
- $38.9B
- P/E
- 68.2
- Sector Median P/E
- 20.7
- F-Score
- 7/9
- ROIC
- 7.0%
- FCF Yield
- 1.6%
With a Tessera Quality Score of 60, ALNY ranks in the top 50% of Healthcare stocks tracked. The stock's P/E of 68.2 sits 230% above the sector median of 20.7. Piotroski F-Score is 7/9; trailing ROIC is 7.0%.
Sector Peers
- Vertex Pharmaceuticals Incorporated (VRTX)Mkt Cap: $109.1B · FCF: 30.3%
- Regeneron Pharmaceuticals, Inc. (REGN)Mkt Cap: $74.2B · FCF: 27.9%
- Verona Pharma plc (VRNA)Mkt Cap: $72.7B · FCF: -43.6%
- argenx SE (ARGX)Mkt Cap: $49.7B · FCF: 12.0%
- Seagen Inc. (SGEN)Mkt Cap: $43.2B · FCF: -30.5%